NEW YORK, July 25, 2017 /PRNewswire/ --
Evercore (NYSE: EVR) announced today that Josh Schimmer has joined the Evercore ISI Healthcare Research team, as a Senior Managing Director, launching Small and Mid-Cap Biotech research coverage. He will also help expand coverage in Large-Cap Biotech. Dr. Schimmer was a runner up in the 2015 and 2016 Institutional Investor's All America Research Team for SMID Biotech. Umer Raffat will continue to lead Evercore ISI's Large-Cap effort across Biotech, Pharma-Major and Specialty Pharma.
Dr. Schimmer was most recently a Managing Director & Senior Research Analyst at Piper Jaffray, covering companies in the Biotech sector. Prior to that, he was a Managing Director at Lazard Capital Markets and held research positions at Leerink Swann, Davidson Kempner and Cowen and Company.
Ed Hyman, Evercore ISI's Founder and Chairman, said, "Evercore ISI is committed to providing our clients with the highest quality independent research analysis and advice, consistently investing in talent to best serve their needs. Josh brings exceptional talent and experience to our Healthcare team, adding materially to the value that we deliver in this strategically important sector."
Umer Raffat said, "Josh will be a very important addition to our biotech effort as we look to further build out our coverage and serve our clients with independent and insightful research."
Josh Schimmer said, "I'm thrilled to join the premiere independent equity research group on the Street, and look forward to providing clients with differentiated analysis of small, mid and select large-cap biotech companies."
Dr. Schimmer holds a Doctor of Medicine degree (MD) from the University of Toronto, where he specialized in Internal Medicine and sub-specialized in Rheumatology. He also holds an MBA from Harvard Business School.
About Evercore
Established in 1995, Evercore is a leading global independent investment banking advisory firm. Evercore advises a diverse set of investment banking clients on a wide range of transactions and issues and provides institutional investors with high quality equity research, sales and trading execution that is free of the conflicts created by proprietary activities. The Firm also offers investment management services to high net worth and institutional investors. With 28 offices and affiliate offices in North America, Europe, South America and Asia, Evercore has the scale and strength to serve clients globally through a focused and tailored approach designed to meet their unique needs. More information about Evercore can be found on the Company's website at www.evercore.com.
Investor Contact: |
Robert B. Walsh |
Chief Financial Officer, Evercore |
|
+1.212.857.3100 |
|
Business Contact: |
Vinayak Singh |
Evercore ISI |
|
+1.212.857.3100 |
|
Media Contact: |
Dana Gorman |
The Abernathy MacGregor Group, for Evercore |
|
+1.212.371.5999 |
SOURCE Evercore
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article